Device manufacturer, as written on reports
Nihon Kohden: medical device reports filed with FDA
7,344 reports name it as the manufacturer of the device involved, 1996–2026.
- 7,344
- reports naming it as manufacturer
- 0% of all MAUDE reports
- 850
- reports, 12 months to August 2026
- 425 in the 12 months before
- 98%
- classified as malfunction
- 62.3% across all reports
- 1.1%
- classified as death, as reported
- 0.9% across all reports
7,344 medical device reports received by FDA give Nihon Kohden as the manufacturer of the device involved, 0% of the MAUDE database, from March 1996 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
850 reports arrived in the 12 months to August 2026, up 100% from 425 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (98%), death (1.1%) and injury (0.7%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Cns-6201a | Monitor, physiological, patient(with arrhythmia detection or alarms) | 1,615 | 0 | 0.8% |
| Cns-6801a | Monitor, physiological, patient(with arrhythmia detection or alarms) | 1,058 | 0 | 1.5% |
| Pu-681ra | Monitor, physiological, patient(with arrhythmia detection or alarms) | 437 | 222 | 1.4% |
| Cns-9700a | Monitor, physiological, patient(with arrhythmia detection or alarms) | 304 | 0 | 0.3% |
| Org-9110a | Transmitters and receivers, physiological signal, radiofrequency | 301 | 59 | 0% |
| Gf-210ra | Analyzer, gas, carbon-dioxide, gaseous-phase | 261 | 0 | 0% |
| Ni | Set, administration, for peritoneal dialysis, disposable | 230 | 1,587 | 1.8% |
| Cns-6201 | Monitor, physiological, patient(with arrhythmia detection or alarms) | 184 | 0 | 0.8% |
| Zm-531pa | Monitor, cardiac (incl. cardiotachometer & rate alarm) | 175 | 38 | 1.1% |
| Gf-210r | Analyzer, gas, carbon-dioxide, gaseous-phase | 171 | 95 | 0% |
| Cns-9700 | Monitor, physiological, patient(with arrhythmia detection or alarms) | 161 | 0 | 1.8% |
| Ag-920ra | Analyzer, gas, carbon-dioxide, gaseous-phase | 112 | 0 | 0% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| MHX | Monitor, physiological, patient(with arrhythmia detection or alarms) | 5,603 | 76.3% |
| CCK | Analyzer, gas, carbon-dioxide, gaseous-phase | 561 | 7.6% |
| DRT | Monitor, cardiac (incl. cardiotachometer & rate alarm) | 529 | 7.2% |
| DRG | Transmitters and receivers, physiological signal, radiofrequency | 497 | 6.8% |
| GWF | Stimulator, electrical, evoked response | 102 | 1.4% |
| GWQ | Full-montage standard electroencephalograph | 16 | 0.2% |
| DXN | System, measurement, blood-pressure, non-invasive | 10 | 0.1% |
| DPS | Electrocardiograph | 5 | 0.1% |
| LDD | Dc-defibrillator, low-energy, (including paddles) | 2 | 0% |
| BZA | Connector, airway (extension) | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Nihon Kohden reports
How many FDA device reports name Nihon Kohden as manufacturer?
7,344 reports through August 2026, 850 of them in the latest 12 months.
Which of its brands appear most often?
Cns-6201a (1,615), Cns-6801a (1,058), Pu-681ra (437), Cns-9700a (304) and Org-9110a (301).
Which device types does it report on?
monitor, physiological, patient(with arrhythmia detection or alarms) (76.3%), analyzer, gas, carbon-dioxide, gaseous-phase (7.6%), monitor, cardiac (incl. cardiotachometer & rate alarm) (7.2%) and transmitters and receivers, physiological signal, radiofrequency (6.8%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.